Moreover, rosuvastatin could suppress NLRP3 inflammasome and IL-1β release in rats with type 2 diabetes and alleviate diabetes-induced cardiac dysfunction [37]. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.